Dylan Powell

Oct 18, 2024 | nature.com | Dylan Powell |Amy Price

Correction to: npj Digital Medicine https://doi.org/10.1038/s41746-024-01261-y, published online 01 October 2024In this article, the author name Dylan Powell was incorrectly written as Dyllan Powell. The original article has been corrected.

Sep 15, 2024 | nature.com | Dylan Powell

Traditional healthcare delivery models face mounting pressure from rising costs, increasing demand, and a growing environmental footprint. Hospital at Home (HaH) has been proposed as a potential solution, offering care at home through in-person, virtual, or hybrid approaches. Despite focus on expanding HaH provision and capacity, research has primarily explored patient care outcomes, patient satisfaction economic costs with a key gap in its environmental impact.

Apr 22, 2024 | nature.com | Dylan Powell

Diagnostics play a crucial role in screening, detecting, and stratifying patients, yet can account for only 2–3% of healthcare spending. With advancements in wearable technology and direct-to-consumer testing, the market for consumer health continues to rise. The potential benefits of more holistic and continuous measurement offer a promising opportunity for earlier disease detection and proactive health management.

Feb 23, 2024 | nature.com | Dylan Powell

The critical role of biomarkersA key pillar of healthcare’s journey towards precision medicine has been the proliferation and development of biomarkers to detect, monitor and manage disease. Over the last fifty years, healthcare has seen a rapid acceleration in the discovery of traditional biomarkers for a variety of conditions, including cancer, namely Carcinoembryonic antigen (CEA), and in the 1980s, CA15-3 for breast cancer1 (Fig. 1).